Guidelines for the Quality Control of Population Pharmacokinetic-Pharmacodynamic Analyses: an Industry Perspective

被引:25
|
作者
Bonate, P. L. [1 ]
Strougo, A. [2 ]
Desai, A. [1 ]
Roy, M. [1 ]
Yassen, A. [2 ]
van der Walt, J. S. [2 ]
Kaibara, A. [3 ]
Tannenbaum, S. [1 ]
机构
[1] Astellas Pharma Global Dev, Northbrook, IL 60062 USA
[2] Astellas Pharma Global Dev, NL-2353W Leiderdorp, Netherlands
[3] Astellas Pharma Inc, Itabashi Ku, Tokyo 1748612, Japan
来源
AAPS JOURNAL | 2012年 / 14卷 / 04期
关键词
modeling; NONMEM; quality assurance; VALIDATION; MODEL;
D O I
10.1208/s12248-012-9387-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quality population modeling and simulation analyses and reports are something every modeler desires. However, little attention in the literature has been paid to what constitutes quality regarding population analyses. Very rarely do published manuscripts contain any statement about quality assurance of the modeling results contained therein. The purpose of this manuscript is to present guidelines for the quality assurance of population analyses, particularly with regards to the use of NONMEM from an industrial perspective. Quality guidelines are developed for the NONMEM installation itself, NONMEM data sets, control streams, output listings, output data files and resultant post-processing, reporting of results, and the review processes. These guidelines were developed to be thorough yet practical, though are not meant to be completely comprehensive. It is our desire to ensure that what is reported accurately reflects the collected data, the modeling process, and model outputs for a modeling project.
引用
收藏
页码:749 / 758
页数:10
相关论文
共 50 条
  • [31] Population-based approach to the assessment of pharmacokinetic-pharmacodynamic data
    Troconiz, IF
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1996, 18 : 51 - 52
  • [32] A population pharmacokinetic-pharmacodynamic and logistic regression analysis of lotrafiban in patients
    Mould, D
    Chapelsky, M
    Aluri, J
    Swagzdis, A
    Samuels, R
    Granett, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (04) : 210 - 222
  • [33] Population Pharmacokinetic-Pharmacodynamic Modeling and Covariate Analyses of Neutropenia and Thrombocytopenia in Patients With Solid Tumors Treated With Lurbinectedin
    Fernandez-Teruel, Carlos
    Lubomirov, Rubin
    Fudio, Salvador
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (09): : 1206 - 1219
  • [34] Pharmacokinetic-Pharmacodynamic Modeling of Apratastat: A Population-Based Approach
    Shu, Cathye
    Zhou, Honghui
    Afsharvand, Mehri
    Duan, Larry
    Zhang, Hui
    Noveck, Robert
    Raible, Donald
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (04): : 472 - 481
  • [35] AN APPLICATION OF BAYESIAN POPULATION PHARMACOKINETIC-PHARMACODYNAMIC MODELS TO DOSE RECOMMENDATION
    WAKEFIELD, J
    RACINEPOON, A
    STATISTICS IN MEDICINE, 1995, 14 (9-10) : 971 - 986
  • [36] Population Pharmacokinetic-Pharmacodynamic Analysis of Istradefylline in Patients With Parkinson Disease
    Knebel, William
    Rao, Niranjan
    Uchimura, T.
    Mori, Akihisa
    Fisher, Jeannine
    Gastonguay, Marc R.
    Chaikin, Philip
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (10): : 1468 - 1481
  • [37] Population pharmacokinetic-pharmacodynamic modeling of subcutaneous and pulmonary insulin in rats
    Gopalakrishnan, M
    Suarez, S
    Hickey, AJ
    Gobburu, J
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2005, 32 (3-4) : 485 - 500
  • [38] Population Pharmacokinetic-Pharmacodynamic Modeling of Intrathecal Ropivacaine in Orthopedic Patients
    Gaudreault, Francois
    Drolet, Pierre
    Fallaha, Michel
    Varin, France
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S95 - S95
  • [39] Clinical pharmacokinetic-pharmacodynamic analyses: a critical element for developing antibacterial agents
    Bhavnani, Sujata M.
    Hammel, Jeffrey P.
    CURRENT OPINION IN PHARMACOLOGY, 2017, 36 : 124 - 129
  • [40] Reporting guidelines for population pharmacokinetic analyses
    Kevin Dykstra
    Nitin Mehrotra
    Christoffer Wenzel Tornøe
    Helen Kastrissios
    Bela Patel
    Nidal Al-Huniti
    Pravin Jadhav
    Yaning Wang
    Wonkyung Byon
    Journal of Pharmacokinetics and Pharmacodynamics, 2015, 42 : 301 - 314